Treatment of lung cancer cells with SM-3 resulted in autophagic cell death, as evidenced by the conversion of LC3I to LC3II, along with increased levels of ATG7, ATG5, and p62 (Fig. 10B). Here, ATG5 is linked to lung cancer.